Delivery Order SPE2DB22D1103-SPE2DB24FTNF5

Award Date 7/9/24
Potential Completion Date 7/10/24
Potential Value $6.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,922.66, is for the delivery of NORDITROPIN FLEXPRO 15 MG/1.5 1.5ML, a specialty medication. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,218.33, is for the delivery of NORDITROPIN FLEXPRO 10 MG/1.5 1.5ML, a specialty medication. This is a firm-fixed-price delivery order contract with a completion date of June 13, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,396.92 firm fixed-price delivery order is for the supply of NORDITROPIN FLEXPRO 15 MG/1.5 1.5ML, a pharmaceutical product. The contract has an ultimate completion date of June 12, 2025 and does not utilize a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,687.80 firm fixed price delivery order is for the supply of NORDITROPIN FLEXPRO 15 MG/1.5 1.5ML products. The contract has an ultimate completion date of October 21, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026 to provide a comprehensive range of...
This federal contract award to AmerisourceBergen Drug Corp (AmerisourceBergen) was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of NORDITROPIN FLEXPRO 10 MG/1.5 1.5ML. The $7,111.66 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
The federal contract award, number SPE2DB22D3004|SPE2DB25FPA95, was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,280.51 contract is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) for the supply of 4566872558 NORDITROPIN FLEXPRO 5 MG/1.5 1.5ML. This contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This contract award to Amerisourcebergen Drug Corp (Amerisourcebergen) was made by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,285.76, is for the delivery of the pharmaceutical product NORDITROPIN FLEXPRO 10 MG/1.5 1.5ML. This is a firm fixed-price delivery order contract with an ultimate completion date of October 11, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to supply a wide range of medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,062.62 Firm Fixed Price delivery order is for the supply of Norditropin FlexPro 10 mg/1.5 ml medication, with a completion date of February 9, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Norditropin FlexPro 15 mg/1.5 ml medication. The $1,891.33 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $1,164.05, is for the delivery of NORDITROPIN FLEXPRO 10 MG/1.5 1.5ML medical products. The contract is a Firm Fixed Price Delivery Order, with a completion date of March 21, 2025. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite...
  • SPE2DB22D1103
    Indefinite Delivery Contract
  • SPE2DB22D1103-SPE2DB24FTNF5
    Delivery Order

This federal contract award, valued at $6,304.94, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NORDITROPIN FLEXPRO 15 MG/1.5 1.5ML, a specialty medication, and does not have a set-aside designation, indicating open competition.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 5/17/25, 10:07 AM